Home

Applications

APPLICATIONS OVERVIEW
DRUG DISCOVERY
ADME-Tox
Biochemical Assays
Cell-based Assays
HTS and Secondary Screening
Microsampling
Protein Crystallography
RNAi
Sample Management
CANCER RESEARCH
Personalized Medicine
Functional Screening / DSRT
RNAi
Sequencing
Single-cell Genomics
GENOMIC RESEARCH
Gene Expression
Genotyping
Microbiome
qPCR
Sequencing
Single-cell Genomics
Synthetic Biology

Products

LIQUID HANDLING
LIQUID HANDLERS OVERVIEW
Echo® 525 Liquid Handler
Echo® 555 Liquid Handler
Echo® 550 Liquid Handler
Echo® 520 Liquid Handler
AUTOMATION
AUTOMATION OVERVIEW
Access™ Laboratory Workstation
Tempo™ Automation Control Software
SOFTWARE APPLICATIONS
SOFTWARE OVERVIEW
Echo® Array Maker
Echo® Cherry Pick
Echo® Combination Screen
Echo® Compliance Manager
Echo® Dose-Response
Echo® Plate Audit
Echo® Plate Reformat
CONSUMABLES
CONSUMABLES OVERVIEW
Echo® Qualified Microplates
Labcyte® Assay Microplates
MicroClime® Environmental Lid
Echo® Qualified Reservoir

Technology

Echo® Acoustic Liquid Handling
Dynamic Fluid Analysis™
Acoustic Mass Spectrometry
Direct Dilution

News / Events

Labcyte BLOG
Upcoming Events
Press Releases
Labcyte in the News
Labcyte Community

Resources

JALA Special Issue
Publications
Articles and Other Media
Application Notes
Posters
Webinars
Videos
Customer Profiles
Core Labs

Support

Brochures
Web Documentation*
User Guides*
Quick Start Guides*
Specification Sheets
Site Prep Guides
Service and Maintenance
Request Information

Company

About Us
Echo® Acoustic Technology
Leadership Team
Meet Labcyte
Careers
Contact and Location
Privacy Policy

Picoliter Inc. One of Top-Ten New Companies of 2001

Picoliter Inc. announced today that the company was selected by Drug Discovery Today as one of the top start-up companies of 2001, as voted by six internationally renowned experts involved in the pharmaceutical/biotechnology industry. In a supplement to the March 1, 2002 issue (Drug Discovery Today, 2002, 7:5:S1-S2), Picoliter and nine other early-to-middle stage companies were profiled and their business strategies were discussed.

March 01, 2002

Mountain View, CA

Mountain View, CA, March 1, 2002—Picoliter Inc. announced today that the company was selected by Drug Discovery Today as one of the top start-up companies of 2001, as voted by six internationally renowned experts involved in the pharmaceutical/biotechnology industry. In a supplement to the March 1, 2002 issue (Drug Discovery Today, 2002, 7:5:S1-S2), Picoliter and nine other early-to-middle stage companies were profiled and their business strategies were discussed.

“We are pleased to be recognized by such a well-respected publication as Drug Discovery Today,” commented Dr. Elaine J. Heron, CEO of Picoliter.  “This article is an excellent introduction to the many applications of our small-volume liquid transfer technology to drug discovery and related applications.”

About Picoliter Inc.
Picoliter Inc. is a development stage company located in Mountain View, CA.  The company has developed a novel technology for moving and analyzing small amounts of liquid using ultrasound energy.  The PicoliterTM liquid handling technology has broad applications in the life science tools market including microarrays, dispensing equipment, and living cell transfer devices.

Members of the Picoliter management team have successfully brought a wide variety of products based on new technologies to market.  The company includes individuals with experience in senior management, manufacturing, business development, intellectual property protection and product development at Affymetrix, Applied Biosystems, Eastman Kodak, International Paper, Molecular Dynamics, Symyx, and Xerox PARC.

About Drug Discovery Today
Drug Discovery Today was launched in 1996 by Elsevier Science London as part of the Trends family of journals.  Since then, Drug Discovery Today has flourished to become a leader in its field: the quality of the editorial content means that it is highly regarded by drug discovery professionals and is seen as an essential source of information.  Drug Discovery Today is the most highly cited journal in drug discovery and is peer-reviewed for authoritative coverage.




MAIN CONTACT
LABCYTE INC.
170 Rose Orchard Way
San Jose, California 95134
USA
Tel:
+1 408 747-2000
Toll-free:
+1 877 742-6548
Sales:
+1 877 742-6548, option 1
Fax:
+1 408 747-2010
Contact:
REQUEST INFO

PRESS CONTACT
Nicole Litchfield
Bioscribe, Inc.
Tel:
+1 415 793-6468
Email:
nicole@bioscribe.com
TOP